BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14626188)

  • 1. [Effect of xuezhikang on blood lipids, serum oxidized low density lipoprotein, C-reactive protein and fibrinogen in patients with unstable angina pectoris].
    Yao QH; Cui CC; Wang JK
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Oct; 23(10):750-2. PubMed ID: 14626188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intervention of xuezhikang on patients of acute coronary syndrome with different levels of blood lipids].
    Wang WH; Zhang H; Yu YL; Ge Z; Xue C; Zhang P
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Dec; 24(12):1073-6. PubMed ID: 15658647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Xuezhikang on serum levels of high sensitive-C reactive protein, matrix metalloproteinase-9 and lipoprotein in patients with acute coronary syndrome].
    Huang J; Wang MH; Peng XP; Wei C; Lu J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Mar; 26(3):221-3. PubMed ID: 16613266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.
    Zhang YC; Wei JJ; Wang F; Chen MT; Zhang MZ
    Cell Biochem Biophys; 2012 Mar; 62(2):365-72. PubMed ID: 21947962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease.
    Hu CL; Li YB; Tang YH; Chen JB; Liu J; Tang QZ; Zhang QH; Huang CX
    Cardiovasc Drugs Ther; 2006 Jun; 20(3):185-91. PubMed ID: 16775668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina.
    Li JJ; Hu SS; Fang CH; Hui RT; Miao LF; Yang YJ; Gao RL
    Clin Chim Acta; 2005 Feb; 352(1-2):217-24. PubMed ID: 15653117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of xuezhikang at different doses on patients suffering from acute coronary syndrome after percutaneous coronary intervention].
    Jiang FY; Sun LP; Yang J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1607-10. PubMed ID: 22384544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease.
    Zhang Q; Ai Y; Dong H; Wang J; Xu L
    IUBMB Life; 2019 Feb; 71(2):277-282. PubMed ID: 30414358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of jingtian tongmai recipe on atherosclerotic plaque in rabbits].
    Zhao CX; Kasimu R; Wang XM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):136-9. PubMed ID: 19382474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris.
    Doo YC; Han SJ; Lee JH; Cho GY; Hong KS; Han KR; Lee NH; Oh DJ; Ryu KH; Rhim CY; Lee KH; Lee Y
    Am J Cardiol; 2004 Mar; 93(5):554-8. PubMed ID: 14996578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia].
    Jian J; Hao X; Deng C; Zhou H; Lin J
    Zhonghua Nei Ke Za Zhi; 1999 Aug; 38(8):517-9. PubMed ID: 11798687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complex link between oxidised low-density lipoprotein and unstable angina.
    Niccoli G; Mongiardo R; Lanza GA; Ricco A; Burzotta F; Trani C; Mazzari MA; Liuzzo G; Lombardo A; Rebuzzi AG; Holvoet P; Crea F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):387-91. PubMed ID: 17443110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes.
    Ehara S; Ueda M; Naruko T; Haze K; Itoh A; Otsuka M; Komatsu R; Matsuo T; Itabe H; Takano T; Tsukamoto Y; Yoshiyama M; Takeuchi K; Yoshikawa J; Becker AE
    Circulation; 2001 Apr; 103(15):1955-60. PubMed ID: 11306523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of xuezhlkang capsule in intervening different Chinese medical syndrome patterns of non-alcoholic fatty liver disease complicated with carotid atherosclerosis].
    Ou MY; Xu SH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):159-63. PubMed ID: 21425565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Xuezhikang on cardiac function, serum C-reactive protein and blood lipid in patients with chronic heart failure].
    Liu ZQ; Cui LQ; Wang Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Mar; 27(3):220-2. PubMed ID: 17432681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia.
    Razavi SM; Gholamin S; Eskandari A; Mohsenian N; Ghorbanihaghjo A; Delazar A; Rashtchizadeh N; Keshtkar-Jahromi M; Argani H
    J Med Food; 2013 Mar; 16(3):255-8. PubMed ID: 23437789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in lipid profile among patients presented with acute myocardial infarction, unstable angina and stable angina pectoris.
    Yang N; Feng JP; Chen G; Kou L; Li Y; Ren P; Zhao LL; Qin Q
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3761-6. PubMed ID: 25555864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulatory effect of yishou tiaozhi tablet on lipids in patients with primary hyperlipidemia].
    Sun L; Jiang J; Chen XY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Apr; 23(4):272-4. PubMed ID: 12764909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance].
    Zhou ZX; Qiang H; Ma AQ; Chen H; Zhou P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):258-62. PubMed ID: 16706128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.
    Ziakas A; Gavrilidis S; Souliou E; Giannoglou G; Stiliadis I; Karvounis H; Efthimiadis G; Mochlas S; Vayona MA; Hatzitolios A; Savopoulos C; Pidonia I; Parharidis G
    Angiology; 2009; 60(1):50-9. PubMed ID: 18388036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.